Eva Miller, MD
Pediatric Allergy/Immunology · Nashville, TNNPI 1225161482
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $126,165 of the $141,348 with a category attached, or 89.3%. AstraZeneca accounts for 93.3% of it on its own, with 23 other manufacturers making up the rest.
Across 525 payments — averaging $269.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$132K
- Amgen$4K
- Sanofi$1K
- GSK$740
- Regeneron Healthcare Solutions, Inc.$590
- Pfizer$490
- plus $2K from 18 others
What the payments were for
- Speaking & faculty fees$126,16589%
- Travel & lodging$4,8013%
- Food & beverage$10,3147%
- Education$680%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 231 | $131,925 |
| Amgen | 17 | $4,124 |
| Sanofi | 48 | $1,103 |
| GSK | 52 | $740 |
| Regeneron Healthcare Solutions, Inc. | 22 | $590 |
| Pfizer | 33 | $490 |
| ARS Pharmaceuticals Operations, Inc. | 15 | $297 |
| CSL Behring | 12 | $274 |
| Novartis | 16 | $267 |
| Kaleo, Inc. | 14 | $263 |
| Genentech USA, Inc. | 12 | $252 |
| Optinose US, Inc. | 12 | $236 |
| Alk-abello, Inc | 8 | $139 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $138 |
| Grifols USA, LLC | 6 | $122 |
| Teva Pharmaceuticals USA, Inc. | 6 | $96 |
| Boehringer Ingelheim | 3 | $60 |
| Azurity Pharmaceuticals, Inc. | 2 | $52 |
| Greer Laboratories, Inc. | 3 | $50 |
| Aimmune Therapeutics, Inc. | 2 | $39 |
| Organon | 2 | $28 |
| Cycle Pharmaceuticals Inc | 1 | $25 |
| Octapharma USA, Inc. | 1 | $20 |
| Galderma Laboratories, L.p. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few pediatric allergy/immunology providers in Tennesseeto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 19 | $867 |
| Fluticasone Propionate | 11 | $423 |
Paid to pharmacies, not to this prescriber.
Other pediatric allergy/immunology in Nashville
- Leonard BacharierNashville$1.2M
- Donna HummellNashville$16K
- Rachel RobisonNashville$14K
- Stacy DorrisNashville$6K
- Yasmin KhanNashville$117
- Allison NortonNashville$24
- Christie MichaelMemphis$13K
- Michael DerrickMurfreesboro$3K
- Annette CarlisleMemphis$1K
- Ashley EscueMemphis$493
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.